(19)
(11) EP 2 981 535 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
10.03.2021 Bulletin 2021/10

(45) Mention of the grant of the patent:
16.12.2020 Bulletin 2020/51

(21) Application number: 14716378.6

(22) Date of filing: 01.04.2014
(51) International Patent Classification (IPC): 
C07D 403/12(2006.01)
C07D 213/74(2006.01)
C07D 405/12(2006.01)
C07D 239/47(2006.01)
A61P 29/00(2006.01)
 C07D 405/14(2006.01)
C07D 401/12(2006.01)
C07D 413/12(2006.01)
A61K 31/505(2006.01)
(86) International application number:
PCT/GB2014/051022
(87) International publication number:
WO 2014/162126 (09.10.2014 Gazette 2014/41)

(54)

UREA DERIVATIVES USEFUL AS KINASE INHIBITORS

ALS KINASEINHIBITOREN NÜTZLICHE HARNSTOFFDERIVATE

DÉRIVÉS D'URÉE UTILISÉS EN TANT QU'INHIBITEURS DE KINASE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 02.04.2013 GB 201305945
20.12.2013 GB 201322678
14.02.2014 GB 201402647

(43) Date of publication of application:
10.02.2016 Bulletin 2016/06

(73) Proprietor: Oxular Acquisitions Limited
Oxford OX4 4GA (GB)

(72) Inventors:
  • FYFE, Matthew Colin Thor
    London WC2R 1BH (GB)
  • THOM, Stephen Malcolm
    Nottingham Nottinghamshire NG1 1GF (GB)
  • BAKER, Thomas Matthew
    Nottingham Nottinghamshire NG1 1GF (GB)
  • HARBOTTLE, Gareth William
    Nottingham Nottinghamshire NG1 1GF (GB)
  • HASIMBEGOVIC, Vedran
    Nottingham Nottinghamshire NG1 1GF (GB)
  • MEGHANI, Premji
    Nottingham Nottinghamshire NG1 1GF (GB)
  • RIGBY, Aaron
    Nottingham Nottinghamshire NG1 1GF (GB)
  • SAMBROOK-SMITH, Colin
    Nottingham Nottinghamshire NG1 1GF (GB)

(74) Representative: Snodin, Michael D. 
Park Grove IP BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF
Nottingham NG1 1GF (GB)


(56) References cited: : 
WO-A1-2004/014870
 WO-A1-2014/027209
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).